Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is now a range of genome- and epigenome-editing techniques (reviewed by Pamies et al., 2018), as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concept of Good Cell Culture Practice (GCCP) (Coecke et al., 2005) was developed and gradually adapted to ongoing scientific progress (Pamies et al., 2018) as a guidance document for in vitro reporting standards.”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“GCCP 2.0 is trying to complement these for stem cell-derived models and microphysiological systems (MPS).”
From Toward good in vitro reporting standards (2019) · cites this paper as Pamies et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Complementarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Pamies et al. 2018
The cited source says what the claim attributes to it.
In the citing paper
“This is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known (Pamies et al., 2018).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct
Pereira, R., Martin, M., Roussel, A., Carribault, P., & Gautier, T. (2023) · Lecture Notes in Computer Science · doi:10.1007/978-3-031-40744-4_5 · Cited by 12,935
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Research works printed but not linked: 1
- altex1406111 · doi:10.14573/altex1406111 · Paper page
Cited by
Evidence-based Guidelines for Controlling pH in Mammalian Live-Cell Culture Systems
Michl, J., Park, K. C., & Swietach, P. (2019) · Communications Biology · doi:10.1038/s42003-019-0393-7 · Cited by 267
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“…form of workshops and supporting guidance documents, such as the OECD Guidance Document (GD) on Good In Vitro Method Practices (OECD, 2018), a recommendation on reporting standards (Hartung et al., 2019) and a Good Cell Culture Practice (GCCP) document for iPSC and MPS (Pamies et al., 2017, 2018).”
BackgroundIn Vitro research Reproducibility: Keeping up High Standards
Hirsch, C., & Schildknecht, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01484 · Cited by 161
Escher, S. E., Kamp, H., Bennekou, S. H., Bitsch, A., Fisher, C., Graepel, R., Hengstler, J. G., Herzler, M., Knight, D. J., Leist, M., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02591-7 · Cited by 166
Metadata
- Authors
- Pamies, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pamies, David
- ORCID
- Pamies, David
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 3
- Pages
- 353-378
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2799414163
- Cited by
- 127
- References
- 140
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 26 · 2019: 15 · 2018: 4
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- University of Twente Research Information (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Joint Research Centre (European Commission) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Horizon 2020 Framework Programme (EU‐H2020, 681002)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- replication crisis, induced pluripotent stem cells, organoids, organ-on-a-chip, primary human cells, cell banks, high-content imaging, high-throughput measurement
- MeSH terms
- Animals, Animal Testing Alternatives, Education, Germany, Humans, Organoids, Quality Control, Guidelines as Topic, Cell Culture Techniques, Pluripotent Stem Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. https://app.cochat.ai/papers/10.14573/altex.1710081
- The paper
- Pamies, D. (2018). Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. ALTEX. https://doi.org/10.14573/altex.1710081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



